Genetic Characterization of HIV Before Widespread Testing of HIV Vaccine Candidates at a Clinical Trial Site in Pretoria, South Africa

被引:0
|
作者
Musyoki, Andrew [1 ]
Mothapo, Khutso [1 ]
Rakgole, Johnny [1 ]
Lukhwareni, Azwidowi [1 ]
Bessong, Pascal [2 ]
Selabe, Gloria [1 ]
Bredell, Helba [3 ]
Williamson, Carolyn [3 ]
Mphahlele, M. Jeffrey [1 ]
机构
[1] Univ Limpopo, Natl Hlth Lab Serv, Dept Virol, HIV & Hepatitis Res Unit, Pretoria, South Africa
[2] Univ Venda, Dept Microbiol, AIDS Virus Res Lab, Thohoyandou, South Africa
[3] Univ Cape Town, Natl Hlth Lab Serv, Div Med Virol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; DIVERSITY; VPR; SEQUENCES; GAG; VIF;
D O I
10.1089/aid.2011.0285
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied 123 samples from adult chronic HIV patients initiating HAART from various centers around a newly established clinical trial site in Pretoria. Each sample was sequenced in at least one structural gene (pol, gag, and env) or functional gene (vif, vpr, and vpu). A subset of 25 samples was subjected to near full-genome analysis. All samples were HIV-1 subtype C. Highly conserved-regions within the gene sequences were observed. Overall, the gag and vif sequences showed closer similarity followed by the env, vpr, pol, and vpu. The env gene was the most difficult to sequence, resulting in only 31 sequences from 40 samples; of these, 25 were predicted to be R5 coreceptor tropic, while 6 were X4 tropic. The study asserted the predominance of HIV-1 subtype C within the catchment population.
引用
收藏
页码:931 / 938
页数:8
相关论文
共 50 条
  • [1] Predominance of HIV Subtype C in Pretoria Region: A New HIV Vaccine Trial Site in South Africa
    Musyoki, A. M.
    Rakgole, J. N.
    Lukhwareni, A.
    Selabe, S. G.
    Mphahlele, M. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 160 - 160
  • [2] Clinical testing of preventive HIV vaccine candidates
    Fast, PE
    Grabowsky, M
    11E COLLOQUE DES CENT GARDES: RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1998, : 273 - 276
  • [3] Selection of HIV vaccine candidates for concurrent testing in an efficacy trial
    Huang, Ying
    DiazGranados, Carlos
    Janes, Holly
    Huang, Yunda
    deCamp, Allan C.
    Metch, Barbara
    Grant, Shannon
    Sanchez, Brittany
    Phogat, Sanjay
    Koutsoukos, Marguerite
    Kanesa-Thasan, Niranjan
    Bourguignon, Patricia
    Collard, Alix
    Buchbinder, Susan
    Tomaras, Georgia D.
    McElrath, Julie
    Gray, Glenda
    Kublin, James G.
    Corey, Lawrence
    Gilbert, Peter B.
    CURRENT OPINION IN VIROLOGY, 2016, 17 : 57 - 65
  • [4] Large HIV Vaccine Trial Launches in South Africa
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 350 - 350
  • [6] HIV vaccine trial participation in South Africa - An ethical assessment
    Moodley, K
    JOURNAL OF MEDICINE AND PHILOSOPHY, 2002, 27 (02): : 197 - 215
  • [7] Review of preventative HIV vaccine clinical trials in South Africa
    Fatima Laher
    Linda-Gail Bekker
    Nigel Garrett
    Erica M. Lazarus
    Glenda E. Gray
    Archives of Virology, 2020, 165 : 2439 - 2452
  • [8] Review of preventative HIV vaccine clinical trials in South Africa
    Laher, Fatima
    Bekker, Linda-Gail
    Garrett, Nigel
    Lazarus, Erica M.
    Gray, Glenda E.
    ARCHIVES OF VIROLOGY, 2020, 165 (11) : 2439 - 2452
  • [9] South Africa begins first HIV vaccine trial in seven years
    Dyer, Owen
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [10] HIV-1c vaccine trial planned for South Africa
    Ramsay, S
    LANCET, 2000, 356 (9238): : 1336 - 1336